Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

The Lancet Respiratory Medicine

Volumn 2, Issue 7, 2014, Pages e8-e9

  Wolkewitz, Martin ^a   Schumacher, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE INHIBITOR; ANTIVIRUS AGENT; ENZYME INHIBITOR; OSELTAMIVIR; SIALIDASE; ZANAMIVIR;

DISEASE SEVERITY; FOLLOW UP; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL DISCHARGE; HUMAN; IMMUNE RESPONSE; INTENSIVE CARE UNIT; LETTER; MORTALITY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL; ANTAGONISTS AND INHIBITORS; FEMALE; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MALE; PANDEMIC;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; ZANAMIVIR;

EID: 84903958274     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70115-8     Document Type: Letter

References (6)

1. Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014, 2:395-404. for the PRIDE Consortium Investigators.
2. Kmietowicz Z Study claiming Tamiflu saved lives was based on "flawed" analysis. BMJ 2014, 348:g2228.
3. Study claiming Tamiflu saved lives was based on "flawed" analysis-recent rapid responses, (accessed June 4, 2014). http://www.bmj.com/content/348/bmj.g2228?tab=responses.
4. Wolkewitz M, Frank U, Philips G, Schumacher M, Davey P Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother 2011, 66:381-386. for the BURDEN study group.
5. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 2009, 35:826-832.
6. Melsen WG, Rovers MM, Groenwold RHH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis 2013, 13:665-671.